

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.10177856 |
| 2 | vocalization behavior (GO:0071625) | 4.93815745 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.92589706 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.92239822 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.92239822 |
| 6 | ribosome assembly (GO:0042255) | 4.78663381 |
| 7 | proteasome assembly (GO:0043248) | 4.76901186 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.71228986 |
| 9 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.66175161 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.60351843 |
| 11 | presynaptic membrane assembly (GO:0097105) | 4.59050466 |
| 12 | glutamate secretion (GO:0014047) | 4.57430766 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.48320879 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.42368444 |
| 15 | establishment of integrated proviral latency (GO:0075713) | 4.38470096 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.36348395 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34852650 |
| 18 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.33171193 |
| 19 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.33171193 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.32539641 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.27241748 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.16744876 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.12103525 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 4.07485344 |
| 25 | transferrin transport (GO:0033572) | 4.07235740 |
| 26 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.06817839 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 4.04716884 |
| 28 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.00483394 |
| 29 | protein localization to synapse (GO:0035418) | 3.96321816 |
| 30 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.94962138 |
| 31 | tRNA aminoacylation for protein translation (GO:0006418) | 3.94086402 |
| 32 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.93187017 |
| 33 | regulation of mitotic spindle organization (GO:0060236) | 3.92970535 |
| 34 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.90769671 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.90553686 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.89023900 |
| 37 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.88063770 |
| 38 | protein maturation by protein folding (GO:0022417) | 3.85881520 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 3.85087856 |
| 40 | tRNA aminoacylation (GO:0043039) | 3.82786487 |
| 41 | amino acid activation (GO:0043038) | 3.82786487 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.82096633 |
| 43 | cullin deneddylation (GO:0010388) | 3.80168219 |
| 44 | ferric iron transport (GO:0015682) | 3.79971366 |
| 45 | trivalent inorganic cation transport (GO:0072512) | 3.79971366 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.79799642 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.78380251 |
| 48 | mitotic metaphase plate congression (GO:0007080) | 3.77767482 |
| 49 | establishment of viral latency (GO:0019043) | 3.77407423 |
| 50 | protein deneddylation (GO:0000338) | 3.77359431 |
| 51 | L-serine metabolic process (GO:0006563) | 3.77140242 |
| 52 | negative regulation of ligase activity (GO:0051352) | 3.73365857 |
| 53 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.73365857 |
| 54 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.72867680 |
| 55 | proline biosynthetic process (GO:0006561) | 3.69474593 |
| 56 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.69030236 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.68945504 |
| 58 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.67777850 |
| 59 | NADH metabolic process (GO:0006734) | 3.67523356 |
| 60 | regulation of translational fidelity (GO:0006450) | 3.62973043 |
| 61 | regulation of spindle organization (GO:0090224) | 3.61867147 |
| 62 | synaptic vesicle maturation (GO:0016188) | 3.57960025 |
| 63 | glutamate receptor signaling pathway (GO:0007215) | 3.54626955 |
| 64 | neurotransmitter transport (GO:0006836) | 3.51726789 |
| 65 | striatum development (GO:0021756) | 3.50403488 |
| 66 | chaperone-mediated protein transport (GO:0072321) | 3.48208836 |
| 67 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.47608487 |
| 68 | nuclear pore complex assembly (GO:0051292) | 3.47200900 |
| 69 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.46498093 |
| 70 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.44133604 |
| 71 | mitotic sister chromatid segregation (GO:0000070) | 3.43878147 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.43856513 |
| 73 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.42349797 |
| 74 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.39874895 |
| 75 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.39125679 |
| 76 | response to histamine (GO:0034776) | 3.37570667 |
| 77 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.36528185 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.35513517 |
| 79 | locomotory exploration behavior (GO:0035641) | 3.35226843 |
| 80 | DNA strand elongation (GO:0022616) | 3.34024545 |
| 81 | IMP biosynthetic process (GO:0006188) | 3.33967972 |
| 82 | proline transport (GO:0015824) | 3.31114872 |
| 83 | positive regulation of ligase activity (GO:0051351) | 3.29429683 |
| 84 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.29348404 |
| 85 | purine nucleobase biosynthetic process (GO:0009113) | 3.28293547 |
| 86 | formation of translation preinitiation complex (GO:0001731) | 3.27587439 |
| 87 | neurotransmitter uptake (GO:0001504) | 3.27437645 |
| 88 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.26396257 |
| 89 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.26029823 |
| 90 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.26029823 |
| 91 | regulation of neurotransmitter levels (GO:0001505) | 3.25623005 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 3.25528743 |
| 93 | mitotic nuclear envelope disassembly (GO:0007077) | 3.24416935 |
| 94 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.24097694 |
| 95 | metaphase plate congression (GO:0051310) | 3.24078134 |
| 96 | positive regulation of synapse assembly (GO:0051965) | 3.23880891 |
| 97 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.22451722 |
| 98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.22451722 |
| 99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.22451722 |
| 100 | startle response (GO:0001964) | 3.22353875 |
| 101 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.21689485 |
| 102 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.21689485 |
| 103 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.19646431 |
| 104 | succinate metabolic process (GO:0006105) | 3.18457728 |
| 105 | tricarboxylic acid cycle (GO:0006099) | 3.16874990 |
| 106 | protein targeting to mitochondrion (GO:0006626) | 3.16785075 |
| 107 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15685842 |
| 108 | mechanosensory behavior (GO:0007638) | 3.14903172 |
| 109 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.14640059 |
| 110 | oxidative phosphorylation (GO:0006119) | 3.14159898 |
| 111 | de novo protein folding (GO:0006458) | 3.14045982 |
| 112 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.13595523 |
| 113 | ATP synthesis coupled proton transport (GO:0015986) | 3.13300982 |
| 114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.13300982 |
| 115 | neuromuscular process controlling posture (GO:0050884) | 3.13014052 |
| 116 | neuron recognition (GO:0008038) | 3.12753474 |
| 117 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.12017611 |
| 118 | ribosome biogenesis (GO:0042254) | 3.10268023 |
| 119 | protein localization to chromosome, centromeric region (GO:0071459) | 3.10056601 |
| 120 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.09960599 |
| 121 | regulation of ligase activity (GO:0051340) | 3.08285488 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 3.07641535 |
| 123 | sister chromatid segregation (GO:0000819) | 3.07510015 |
| 124 | de novo posttranslational protein folding (GO:0051084) | 3.07054080 |
| 125 | nuclear pore organization (GO:0006999) | 3.07053148 |
| 126 | protein localization to kinetochore (GO:0034501) | 3.06805560 |
| 127 | behavioral response to cocaine (GO:0048148) | 3.03879221 |
| 128 | transmission of nerve impulse (GO:0019226) | 3.03090251 |
| 129 | regulation of neurotransmitter transport (GO:0051588) | 2.99718594 |
| 130 | regulation of postsynaptic membrane potential (GO:0060078) | 2.99580323 |
| 131 | membrane disassembly (GO:0030397) | 2.98961463 |
| 132 | nuclear envelope disassembly (GO:0051081) | 2.98961463 |
| 133 | DNA unwinding involved in DNA replication (GO:0006268) | 2.98611174 |
| 134 | positive regulation of membrane potential (GO:0045838) | 2.97709352 |
| 135 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.97370910 |
| 136 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.96761681 |
| 137 | spliceosomal snRNP assembly (GO:0000387) | 2.96437928 |
| 138 | regulation of synapse structural plasticity (GO:0051823) | 2.96043117 |
| 139 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.94949081 |
| 140 | positive regulation of neurotransmitter transport (GO:0051590) | 2.94941246 |
| 141 | respiratory electron transport chain (GO:0022904) | 2.94217415 |
| 142 | synaptic transmission (GO:0007268) | 2.93241704 |
| 143 | exploration behavior (GO:0035640) | 2.92691064 |
| 144 | nucleobase biosynthetic process (GO:0046112) | 2.92407772 |
| 145 | negative regulation of neurotransmitter transport (GO:0051589) | 2.91244366 |
| 146 | negative regulation of dendrite development (GO:2000171) | 2.90382010 |
| 147 | positive regulation of synapse maturation (GO:0090129) | 2.90104427 |
| 148 | IMP metabolic process (GO:0046040) | 2.89870903 |
| 149 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.88886711 |
| 150 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.88886711 |
| 151 | electron transport chain (GO:0022900) | 2.88885202 |
| 152 | protein localization to mitochondrion (GO:0070585) | 2.88231478 |
| 153 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.88017766 |
| 154 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87698440 |
| 155 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.86920799 |
| 156 | rRNA modification (GO:0000154) | 2.86855172 |
| 157 | pore complex assembly (GO:0046931) | 2.86850070 |
| 158 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.86564322 |
| 159 | phagosome maturation (GO:0090382) | 2.85390560 |
| 160 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.85256041 |
| 161 | non-recombinational repair (GO:0000726) | 2.85256041 |
| 162 | membrane hyperpolarization (GO:0060081) | 2.83934136 |
| 163 | female mating behavior (GO:0060180) | 2.83774661 |
| 164 | establishment of protein localization to mitochondrion (GO:0072655) | 2.83689692 |
| 165 | regulation of synaptic plasticity (GO:0048167) | 2.83456702 |
| 166 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.83034503 |
| 167 | regulation of glutamate secretion (GO:0014048) | 2.82967073 |
| 168 | positive regulation of synaptic transmission (GO:0050806) | 2.81921414 |
| 169 | synaptic vesicle endocytosis (GO:0048488) | 2.81661890 |
| 170 | establishment of synaptic vesicle localization (GO:0097480) | 2.81388546 |
| 171 | synaptic vesicle transport (GO:0048489) | 2.81388546 |
| 172 | protein complex biogenesis (GO:0070271) | 2.81278374 |
| 173 | mitochondrial RNA metabolic process (GO:0000959) | 2.81123338 |
| 174 | regulation of cellular amine metabolic process (GO:0033238) | 2.80730593 |
| 175 | membrane depolarization during action potential (GO:0086010) | 2.80614666 |
| 176 | synapse assembly (GO:0007416) | 2.80289583 |
| 177 | oxaloacetate metabolic process (GO:0006107) | 2.80069181 |
| 178 | ribosomal large subunit biogenesis (GO:0042273) | 2.77780990 |
| 179 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.75114497 |
| 180 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.73006056 |
| 181 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.72536686 |
| 182 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72497882 |
| 183 | nuclear envelope reassembly (GO:0031468) | 2.69551821 |
| 184 | mitotic nuclear envelope reassembly (GO:0007084) | 2.69551821 |
| 185 | DNA ligation (GO:0006266) | 2.68988015 |
| 186 | cell cycle G1/S phase transition (GO:0044843) | 2.68362593 |
| 187 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.68362593 |
| 188 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.66772320 |
| 189 | serine family amino acid biosynthetic process (GO:0009070) | 2.66768347 |
| 190 | telomere maintenance via recombination (GO:0000722) | 2.66338799 |
| 191 | proline metabolic process (GO:0006560) | 2.65791893 |
| 192 | establishment of chromosome localization (GO:0051303) | 2.65166902 |
| 193 | protein complex localization (GO:0031503) | 2.65112682 |
| 194 | fatty acid elongation (GO:0030497) | 2.64492927 |
| 195 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.64012676 |
| 196 | spindle checkpoint (GO:0031577) | 2.61076949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20120956 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.80286039 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.77057385 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.65000644 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.91704309 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.71442602 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.64325802 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.58101691 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.46451708 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.36629374 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.18922684 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.18531307 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.11510878 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.97058218 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91741975 |
| 16 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.91325525 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.90727606 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.86457956 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79167892 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.76335483 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.74170102 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.72080695 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.67588943 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.65526537 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59706806 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.57451106 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57025480 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.52871860 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.52293500 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.51698595 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.45713519 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.43902909 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.42075875 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36469952 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.34449264 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33972746 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29081986 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.26716864 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25465916 |
| 40 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23927038 |
| 41 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23892282 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23226339 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.22714811 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.21969488 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.20539109 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16720668 |
| 47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16720668 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.16547119 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14706135 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.12556295 |
| 51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.12156138 |
| 52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.09858267 |
| 53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09091599 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06536646 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05387172 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.01041779 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94673822 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.94336202 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94315687 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.94235470 |
| 61 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92510146 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92447592 |
| 63 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.91749493 |
| 64 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91192230 |
| 65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.89331721 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.87990004 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87156672 |
| 68 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86237185 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85526860 |
| 70 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84249801 |
| 71 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.83385747 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81284307 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79550261 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79462491 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78789178 |
| 76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78297362 |
| 77 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77044151 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76313831 |
| 79 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.72801341 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71429945 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69374082 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68191517 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67744656 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.67661616 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67593575 |
| 86 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65926860 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63939997 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60913236 |
| 89 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.60871949 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.59537654 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59158978 |
| 92 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58633460 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58606253 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57389579 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56640451 |
| 96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55972548 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55573497 |
| 98 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55062888 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54470135 |
| 100 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.54128462 |
| 101 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.51672918 |
| 102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49866338 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49608460 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48634866 |
| 105 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47307179 |
| 106 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46123534 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46048506 |
| 108 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.44153206 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42503203 |
| 110 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42388933 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42341947 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41776061 |
| 113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36260698 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35411025 |
| 115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.34101393 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32927854 |
| 117 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32501908 |
| 118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32119047 |
| 119 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.32014793 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31329781 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29765574 |
| 122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.29695587 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.29024070 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28830430 |
| 125 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24133182 |
| 126 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23028831 |
| 127 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22807113 |
| 128 | JUN_21703547_ChIP-Seq_K562_Human | 1.22621152 |
| 129 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22009753 |
| 130 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21423830 |
| 131 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20837080 |
| 132 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20294867 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19952810 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19261971 |
| 135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18712381 |
| 136 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18488562 |
| 137 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18441303 |
| 138 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17832653 |
| 139 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17818061 |
| 140 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13119378 |
| 141 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.12879584 |
| 142 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12716893 |
| 143 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12349144 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11852108 |
| 145 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11730488 |
| 146 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11598146 |
| 147 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10956347 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10213064 |
| 149 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09861568 |
| 150 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09534135 |
| 151 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.09224521 |
| 152 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08973767 |
| 153 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.08024211 |
| 154 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08015959 |
| 155 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07725450 |
| 156 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07648016 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07210557 |
| 158 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06784189 |
| 159 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05316314 |
| 160 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04779351 |
| 161 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04764141 |
| 162 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04666984 |
| 163 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02668656 |
| 164 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00662817 |
| 165 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00543654 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00162140 |
| 167 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.00069929 |
| 168 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99599888 |
| 169 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99515563 |
| 170 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98836163 |
| 171 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98602850 |
| 172 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.97002675 |
| 173 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96902143 |
| 174 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96653014 |
| 175 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96154645 |
| 176 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95433649 |
| 177 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94969486 |
| 178 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.94879609 |
| 179 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94600588 |
| 180 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94161062 |
| 181 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93664532 |
| 182 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93471373 |
| 183 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92995782 |
| 184 | AR_19668381_ChIP-Seq_PC3_Human | 0.92496142 |
| 185 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91696550 |
| 186 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91208199 |
| 187 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90350904 |
| 188 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89858222 |
| 189 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88811112 |
| 190 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.88761633 |
| 191 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87879112 |
| 192 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.87737805 |
| 193 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87352263 |
| 194 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.86738472 |
| 195 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.86424987 |
| 196 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.83385592 |
| 197 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81903017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.80284612 |
| 2 | MP0003880_abnormal_central_pattern | 4.79141082 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.38874781 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 4.07139053 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.79520584 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.71635633 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.50555247 |
| 8 | MP0009046_muscle_twitch | 3.46888991 |
| 9 | MP0008932_abnormal_embryonic_tissue | 3.35641474 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.33355332 |
| 11 | MP0009745_abnormal_behavioral_response | 3.30560512 |
| 12 | MP0002064_seizures | 3.20713692 |
| 13 | MP0008058_abnormal_DNA_repair | 3.15941954 |
| 14 | MP0001968_abnormal_touch/_nociception | 3.14863937 |
| 15 | MP0003077_abnormal_cell_cycle | 3.12495270 |
| 16 | MP0002736_abnormal_nociception_after | 2.97112462 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.96952528 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.86842595 |
| 19 | MP0004270_analgesia | 2.79187407 |
| 20 | MP0002272_abnormal_nervous_system | 2.72702047 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.70824487 |
| 22 | MP0001529_abnormal_vocalization | 2.69952027 |
| 23 | MP0002822_catalepsy | 2.66471228 |
| 24 | MP0003718_maternal_effect | 2.53692192 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.52604845 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.52194178 |
| 27 | MP0003186_abnormal_redox_activity | 2.49179326 |
| 28 | MP0005408_hypopigmentation | 2.46216885 |
| 29 | MP0001486_abnormal_startle_reflex | 2.38710397 |
| 30 | MP0005646_abnormal_pituitary_gland | 2.34804416 |
| 31 | MP0006276_abnormal_autonomic_nervous | 2.28405897 |
| 32 | MP0001730_embryonic_growth_arrest | 2.26179676 |
| 33 | MP0001501_abnormal_sleep_pattern | 2.20420758 |
| 34 | MP0002067_abnormal_sensory_capabilities | 2.14183320 |
| 35 | MP0001440_abnormal_grooming_behavior | 2.13842500 |
| 36 | MP0001984_abnormal_olfaction | 2.09790649 |
| 37 | MP0003122_maternal_imprinting | 2.05517554 |
| 38 | MP0005423_abnormal_somatic_nervous | 2.04782664 |
| 39 | MP0001905_abnormal_dopamine_level | 1.98573917 |
| 40 | MP0004142_abnormal_muscle_tone | 1.95511624 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.95310538 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.90485632 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.90471707 |
| 44 | MP0003787_abnormal_imprinting | 1.89908970 |
| 45 | MP0000358_abnormal_cell_content/ | 1.89662736 |
| 46 | MP0001970_abnormal_pain_threshold | 1.88647425 |
| 47 | MP0003786_premature_aging | 1.86196361 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.83531844 |
| 49 | MP0004924_abnormal_behavior | 1.83531844 |
| 50 | MP0008260_abnormal_autophagy | 1.72627858 |
| 51 | MP0003941_abnormal_skin_development | 1.70499148 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.69413026 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.65027352 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.64993802 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.64985775 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.60948017 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.59213590 |
| 58 | MP0002080_prenatal_lethality | 1.58436110 |
| 59 | MP0008569_lethality_at_weaning | 1.58293767 |
| 60 | MP0002184_abnormal_innervation | 1.56609917 |
| 61 | MP0000778_abnormal_nervous_system | 1.53128493 |
| 62 | MP0005380_embryogenesis_phenotype | 1.51371340 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.51371340 |
| 64 | MP0003879_abnormal_hair_cell | 1.49881597 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.49815876 |
| 66 | MP0001697_abnormal_embryo_size | 1.49581593 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.48769284 |
| 68 | MP0001188_hyperpigmentation | 1.43657559 |
| 69 | MP0003329_amyloid_beta_deposits | 1.43091034 |
| 70 | MP0001764_abnormal_homeostasis | 1.41704495 |
| 71 | MP0005171_absent_coat_pigmentation | 1.35470725 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.35464509 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.35382941 |
| 74 | MP0004811_abnormal_neuron_physiology | 1.34793627 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.34780948 |
| 76 | MP0000751_myopathy | 1.32714660 |
| 77 | MP0009840_abnormal_foam_cell | 1.30697617 |
| 78 | MP0003984_embryonic_growth_retardation | 1.29077218 |
| 79 | MP0002882_abnormal_neuron_morphology | 1.27176599 |
| 80 | MP0000955_abnormal_spinal_cord | 1.24246163 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.20039984 |
| 82 | MP0000313_abnormal_cell_death | 1.19958984 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 1.19848216 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 1.19499147 |
| 85 | MP0005501_abnormal_skin_physiology | 1.18508152 |
| 86 | MP0004858_abnormal_nervous_system | 1.18385318 |
| 87 | MP0008872_abnormal_physiological_respon | 1.15939464 |
| 88 | MP0003633_abnormal_nervous_system | 1.15500643 |
| 89 | MP0004043_abnormal_pH_regulation | 1.14624587 |
| 90 | MP0004215_abnormal_myocardial_fiber | 1.11690364 |
| 91 | MP0001502_abnormal_circadian_rhythm | 1.10832485 |
| 92 | MP0001661_extended_life_span | 1.10243920 |
| 93 | MP0002909_abnormal_adrenal_gland | 1.09825016 |
| 94 | MP0002229_neurodegeneration | 1.09653913 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 1.07402953 |
| 96 | MP0003631_nervous_system_phenotype | 1.07178672 |
| 97 | MP0002084_abnormal_developmental_patter | 1.06418560 |
| 98 | MP0009672_abnormal_birth_weight | 1.03993973 |
| 99 | MP0005330_cardiomyopathy | 1.03039810 |
| 100 | MP0001963_abnormal_hearing_physiology | 1.02494356 |
| 101 | MP0010386_abnormal_urinary_bladder | 1.01593466 |
| 102 | MP0003315_abnormal_perineum_morphology | 1.01236729 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 1.00272992 |
| 104 | MP0000013_abnormal_adipose_tissue | 0.98781835 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.98768736 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.98657793 |
| 107 | MP0004147_increased_porphyrin_level | 0.98567813 |
| 108 | MP0002085_abnormal_embryonic_tissue | 0.98550074 |
| 109 | MP0005384_cellular_phenotype | 0.98525721 |
| 110 | MP0004885_abnormal_endolymph | 0.98216634 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.97729669 |
| 112 | MP0008789_abnormal_olfactory_epithelium | 0.97112757 |
| 113 | MP0008877_abnormal_DNA_methylation | 0.96055466 |
| 114 | MP0002796_impaired_skin_barrier | 0.95429948 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.94209154 |
| 116 | MP0008057_abnormal_DNA_replication | 0.94068504 |
| 117 | MP0004742_abnormal_vestibular_system | 0.93710188 |
| 118 | MP0002086_abnormal_extraembryonic_tissu | 0.93283903 |
| 119 | MP0003646_muscle_fatigue | 0.92674876 |
| 120 | MP0005451_abnormal_body_composition | 0.90881284 |
| 121 | MP0004085_abnormal_heartbeat | 0.90486046 |
| 122 | MP0002152_abnormal_brain_morphology | 0.89736909 |
| 123 | MP0009697_abnormal_copulation | 0.89353424 |
| 124 | MP0001853_heart_inflammation | 0.89107226 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89016327 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.88645862 |
| 127 | MP0000647_abnormal_sebaceous_gland | 0.88384039 |
| 128 | MP0003690_abnormal_glial_cell | 0.88339709 |
| 129 | MP0004272_abnormal_basement_membrane | 0.88279349 |
| 130 | MP0001881_abnormal_mammary_gland | 0.87601873 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.86991935 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.86628168 |
| 133 | MP0006036_abnormal_mitochondrial_physio | 0.86586149 |
| 134 | MP0005165_increased_susceptibility_to | 0.86140483 |
| 135 | MP0005332_abnormal_amino_acid | 0.84575819 |
| 136 | MP0000749_muscle_degeneration | 0.84232067 |
| 137 | MP0005499_abnormal_olfactory_system | 0.84039582 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.84039582 |
| 139 | MP0001664_abnormal_digestion | 0.83595126 |
| 140 | MP0003634_abnormal_glial_cell | 0.82642792 |
| 141 | MP0003121_genomic_imprinting | 0.82579553 |
| 142 | MP0003632_abnormal_nervous_system | 0.82234766 |
| 143 | MP0005257_abnormal_intraocular_pressure | 0.81563715 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.81105983 |
| 145 | MP0002752_abnormal_somatic_nervous | 0.79975791 |
| 146 | MP0005395_other_phenotype | 0.79668178 |
| 147 | MP0000537_abnormal_urethra_morphology | 0.79391186 |
| 148 | MP0005535_abnormal_body_temperature | 0.79179839 |
| 149 | MP0000631_abnormal_neuroendocrine_gland | 0.77703547 |
| 150 | MP0002269_muscular_atrophy | 0.77350003 |
| 151 | MP0004036_abnormal_muscle_relaxation | 0.77250591 |
| 152 | MP0001485_abnormal_pinna_reflex | 0.76848516 |
| 153 | MP0005365_abnormal_bile_salt | 0.75734506 |
| 154 | MP0005621_abnormal_cell_physiology | 0.74616724 |
| 155 | MP0001177_atelectasis | 0.73997694 |
| 156 | MP0003137_abnormal_impulse_conducting | 0.71574946 |
| 157 | MP0005360_urolithiasis | 0.71397001 |
| 158 | MP0001915_intracranial_hemorrhage | 0.71373489 |
| 159 | MP0005319_abnormal_enzyme/_coenzyme | 0.70667764 |
| 160 | MP0004484_altered_response_of | 0.69295738 |
| 161 | MP0002060_abnormal_skin_morphology | 0.67974442 |
| 162 | MP0000747_muscle_weakness | 0.67861286 |
| 163 | MP0004197_abnormal_fetal_growth/weight/ | 0.67735736 |
| 164 | MP0008874_decreased_physiological_sensi | 0.67079053 |
| 165 | MP0004145_abnormal_muscle_electrophysio | 0.66061304 |
| 166 | MP0000026_abnormal_inner_ear | 0.65362386 |
| 167 | MP0000627_abnormal_mammary_gland | 0.65223535 |
| 168 | MP0000613_abnormal_salivary_gland | 0.65212102 |
| 169 | MP0004264_abnormal_extraembryonic_tissu | 0.64615799 |
| 170 | MP0000920_abnormal_myelination | 0.64191849 |
| 171 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63182508 |
| 172 | MP0004185_abnormal_adipocyte_glucose | 0.63112337 |
| 173 | MP0002332_abnormal_exercise_endurance | 0.62598524 |
| 174 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62594696 |
| 175 | MP0002102_abnormal_ear_morphology | 0.62028393 |
| 176 | MP0001929_abnormal_gametogenesis | 0.62019797 |
| 177 | MP0002111_abnormal_tail_morphology | 0.60742445 |
| 178 | MP0002139_abnormal_hepatobiliary_system | 0.60466881 |
| 179 | MP0000762_abnormal_tongue_morphology | 0.60358495 |
| 180 | MP0003123_paternal_imprinting | 0.58637287 |
| 181 | MP0000598_abnormal_liver_morphology | 0.58587258 |
| 182 | MP0001216_abnormal_epidermal_layer | 0.58446623 |
| 183 | MP0004233_abnormal_muscle_weight | 0.58104765 |
| 184 | MP0010307_abnormal_tumor_latency | 0.58013200 |
| 185 | MP0001943_abnormal_respiration | 0.57778367 |
| 186 | MP0001666_abnormal_nutrient_absorption | 0.56971684 |
| 187 | MP0002938_white_spotting | 0.56884016 |
| 188 | MP0002090_abnormal_vision | 0.56581529 |
| 189 | MP0002210_abnormal_sex_determination | 0.53686141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.37422731 |
| 2 | Atonic seizures (HP:0010819) | 5.40908370 |
| 3 | Epileptic encephalopathy (HP:0200134) | 4.88976452 |
| 4 | Febrile seizures (HP:0002373) | 4.67249733 |
| 5 | Myokymia (HP:0002411) | 4.64656105 |
| 6 | Focal seizures (HP:0007359) | 4.47469851 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.31146497 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.21414621 |
| 9 | Hyperventilation (HP:0002883) | 4.19597502 |
| 10 | Pheochromocytoma (HP:0002666) | 4.12245784 |
| 11 | Absence seizures (HP:0002121) | 3.90730974 |
| 12 | Neuroendocrine neoplasm (HP:0100634) | 3.87859939 |
| 13 | Progressive macrocephaly (HP:0004481) | 3.79238151 |
| 14 | Dialeptic seizures (HP:0011146) | 3.65295289 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.62164014 |
| 16 | Visual hallucinations (HP:0002367) | 3.56807448 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.49079290 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.49079290 |
| 19 | Acute encephalopathy (HP:0006846) | 3.48341910 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.48110109 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 3.37195125 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.36874631 |
| 23 | Abnormal hair whorl (HP:0010721) | 3.34377420 |
| 24 | Hepatocellular necrosis (HP:0001404) | 3.32299023 |
| 25 | Microvesicular hepatic steatosis (HP:0001414) | 3.30991777 |
| 26 | Increased CSF lactate (HP:0002490) | 3.29079546 |
| 27 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.26643685 |
| 28 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.26643685 |
| 29 | Abnormal protein glycosylation (HP:0012346) | 3.26643685 |
| 30 | Abnormal glycosylation (HP:0012345) | 3.26643685 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 3.22359818 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.18236858 |
| 33 | Gait imbalance (HP:0002141) | 3.07048629 |
| 34 | Limb dystonia (HP:0002451) | 3.00345149 |
| 35 | Congenital primary aphakia (HP:0007707) | 2.90155021 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.89948559 |
| 37 | Ragged-red muscle fibers (HP:0003200) | 2.89141574 |
| 38 | Polyphagia (HP:0002591) | 2.88467425 |
| 39 | Nephrogenic diabetes insipidus (HP:0009806) | 2.87034763 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.85712008 |
| 41 | Poor suck (HP:0002033) | 2.79923858 |
| 42 | Hypokinesia (HP:0002375) | 2.78245900 |
| 43 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.76603730 |
| 44 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.76603730 |
| 45 | Broad-based gait (HP:0002136) | 2.72720518 |
| 46 | Failure to thrive in infancy (HP:0001531) | 2.67603871 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.62742733 |
| 48 | Degeneration of anterior horn cells (HP:0002398) | 2.53077646 |
| 49 | Abnormality of the anterior horn cell (HP:0006802) | 2.53077646 |
| 50 | Hepatic necrosis (HP:0002605) | 2.52261545 |
| 51 | Truncal ataxia (HP:0002078) | 2.52008105 |
| 52 | Secondary amenorrhea (HP:0000869) | 2.51673013 |
| 53 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.50431635 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.43997834 |
| 55 | Optic disc pallor (HP:0000543) | 2.43979615 |
| 56 | Postnatal microcephaly (HP:0005484) | 2.42164522 |
| 57 | Leukodystrophy (HP:0002415) | 2.42154603 |
| 58 | Hyperammonemia (HP:0001987) | 2.40827152 |
| 59 | Anxiety (HP:0000739) | 2.39543316 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.38807546 |
| 61 | Abnormality of methionine metabolism (HP:0010901) | 2.37748749 |
| 62 | Hypothermia (HP:0002045) | 2.35166959 |
| 63 | Spastic paraparesis (HP:0002313) | 2.33567303 |
| 64 | Scanning speech (HP:0002168) | 2.33222686 |
| 65 | Upper limb muscle weakness (HP:0003484) | 2.32939947 |
| 66 | Oligomenorrhea (HP:0000876) | 2.30360477 |
| 67 | Progressive inability to walk (HP:0002505) | 2.29854503 |
| 68 | Lactic acidosis (HP:0003128) | 2.28852846 |
| 69 | Vaginal atresia (HP:0000148) | 2.28639517 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.28603645 |
| 71 | Genital tract atresia (HP:0001827) | 2.28457571 |
| 72 | Specific learning disability (HP:0001328) | 2.26124471 |
| 73 | Poor eye contact (HP:0000817) | 2.24552738 |
| 74 | CNS hypomyelination (HP:0003429) | 2.23277672 |
| 75 | EEG with generalized epileptiform discharges (HP:0011198) | 2.22889311 |
| 76 | Premature ovarian failure (HP:0008209) | 2.21842657 |
| 77 | Cerebral edema (HP:0002181) | 2.21049877 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 2.20845392 |
| 79 | Cholelithiasis (HP:0001081) | 2.20200310 |
| 80 | Respiratory failure (HP:0002878) | 2.18942586 |
| 81 | Amblyopia (HP:0000646) | 2.18700079 |
| 82 | Abnormality of binocular vision (HP:0011514) | 2.18232718 |
| 83 | Diplopia (HP:0000651) | 2.18232718 |
| 84 | Ependymoma (HP:0002888) | 2.16280788 |
| 85 | Poor coordination (HP:0002370) | 2.15894920 |
| 86 | Abnormality of the umbilical cord (HP:0010881) | 2.15448706 |
| 87 | Inability to walk (HP:0002540) | 2.15434141 |
| 88 | Depression (HP:0000716) | 2.14577802 |
| 89 | Microglossia (HP:0000171) | 2.14514601 |
| 90 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.13653852 |
| 91 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.13354222 |
| 92 | Blue irides (HP:0000635) | 2.13264003 |
| 93 | Abnormal gallbladder morphology (HP:0012437) | 2.13034384 |
| 94 | Insidious onset (HP:0003587) | 2.12519372 |
| 95 | Ankle clonus (HP:0011448) | 2.12187049 |
| 96 | Hypsarrhythmia (HP:0002521) | 2.10815841 |
| 97 | Sparse eyelashes (HP:0000653) | 2.10301968 |
| 98 | Fetal akinesia sequence (HP:0001989) | 2.10061934 |
| 99 | Cortical dysplasia (HP:0002539) | 2.09328598 |
| 100 | Autoamputation (HP:0001218) | 2.08512400 |
| 101 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08074126 |
| 102 | Impaired social interactions (HP:0000735) | 2.07533436 |
| 103 | Abnormal social behavior (HP:0012433) | 2.07533436 |
| 104 | Exercise intolerance (HP:0003546) | 2.06498540 |
| 105 | Gout (HP:0001997) | 2.05979624 |
| 106 | Abnormality of the labia minora (HP:0012880) | 2.04404045 |
| 107 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04399553 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 2.04399553 |
| 109 | Hyperalaninemia (HP:0003348) | 2.04399553 |
| 110 | Cholecystitis (HP:0001082) | 2.02923373 |
| 111 | Abnormal gallbladder physiology (HP:0012438) | 2.02923373 |
| 112 | Progressive muscle weakness (HP:0003323) | 1.98857417 |
| 113 | Death in infancy (HP:0001522) | 1.95803582 |
| 114 | Lethargy (HP:0001254) | 1.95376028 |
| 115 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95312902 |
| 116 | Dysmetria (HP:0001310) | 1.94758057 |
| 117 | Progressive external ophthalmoplegia (HP:0000590) | 1.94733512 |
| 118 | Hand muscle atrophy (HP:0009130) | 1.93816215 |
| 119 | Narrow nasal bridge (HP:0000446) | 1.93589798 |
| 120 | Hypobetalipoproteinemia (HP:0003563) | 1.92962512 |
| 121 | Emotional lability (HP:0000712) | 1.92827248 |
| 122 | Shoulder girdle muscle weakness (HP:0003547) | 1.92385929 |
| 123 | Testicular atrophy (HP:0000029) | 1.92217507 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91420442 |
| 125 | Action tremor (HP:0002345) | 1.89110472 |
| 126 | Increased serum lactate (HP:0002151) | 1.88787497 |
| 127 | Rhabdomyolysis (HP:0003201) | 1.88703642 |
| 128 | Spastic gait (HP:0002064) | 1.88215192 |
| 129 | Bradykinesia (HP:0002067) | 1.88109371 |
| 130 | Drooling (HP:0002307) | 1.87689364 |
| 131 | Excessive salivation (HP:0003781) | 1.87689364 |
| 132 | Sensorimotor neuropathy (HP:0007141) | 1.87097942 |
| 133 | Resting tremor (HP:0002322) | 1.86945303 |
| 134 | Protruding tongue (HP:0010808) | 1.86534980 |
| 135 | Abnormality of the corticospinal tract (HP:0002492) | 1.85936146 |
| 136 | Esotropia (HP:0000565) | 1.85873243 |
| 137 | Spastic diplegia (HP:0001264) | 1.85723358 |
| 138 | Rough bone trabeculation (HP:0100670) | 1.85235161 |
| 139 | X-linked dominant inheritance (HP:0001423) | 1.84056062 |
| 140 | Progressive microcephaly (HP:0000253) | 1.83716866 |
| 141 | Hyperglycinemia (HP:0002154) | 1.82787529 |
| 142 | Focal dystonia (HP:0004373) | 1.82439171 |
| 143 | Sensory axonal neuropathy (HP:0003390) | 1.81921660 |
| 144 | Impaired pain sensation (HP:0007328) | 1.81198684 |
| 145 | Abnormality of pain sensation (HP:0010832) | 1.81198684 |
| 146 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.80574057 |
| 147 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.80574057 |
| 148 | Single umbilical artery (HP:0001195) | 1.80574057 |
| 149 | Patchy hypopigmentation of hair (HP:0011365) | 1.80475387 |
| 150 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79999488 |
| 151 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.79907778 |
| 152 | Hemiparesis (HP:0001269) | 1.79679266 |
| 153 | Generalized myoclonic seizures (HP:0002123) | 1.79667982 |
| 154 | Impaired vibratory sensation (HP:0002495) | 1.79382964 |
| 155 | Status epilepticus (HP:0002133) | 1.78898443 |
| 156 | Abnormality of placental membranes (HP:0011409) | 1.77720994 |
| 157 | Amniotic constriction ring (HP:0009775) | 1.77720994 |
| 158 | CNS demyelination (HP:0007305) | 1.77051548 |
| 159 | Torticollis (HP:0000473) | 1.75571597 |
| 160 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.75211738 |
| 161 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.75211738 |
| 162 | Hypoventilation (HP:0002791) | 1.73222868 |
| 163 | Termporal pattern (HP:0011008) | 1.72827592 |
| 164 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72419026 |
| 165 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72305197 |
| 166 | Abnormality of glycine metabolism (HP:0010895) | 1.72305197 |
| 167 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.72113066 |
| 168 | Neoplasm of the adrenal gland (HP:0100631) | 1.71517753 |
| 169 | Opisthotonus (HP:0002179) | 1.70066125 |
| 170 | Hypoglycemic coma (HP:0001325) | 1.69427909 |
| 171 | Microretrognathia (HP:0000308) | 1.69242306 |
| 172 | Hyperglycinuria (HP:0003108) | 1.67743788 |
| 173 | Vertebral compression fractures (HP:0002953) | 1.66019685 |
| 174 | Intrahepatic cholestasis (HP:0001406) | 1.65289682 |
| 175 | Abnormality of the gallbladder (HP:0005264) | 1.64487479 |
| 176 | Increased nuchal translucency (HP:0010880) | 1.63379058 |
| 177 | Palpitations (HP:0001962) | 1.60852337 |
| 178 | Facial cleft (HP:0002006) | 1.60070047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.25464065 |
| 2 | BUB1 | 4.08410058 |
| 3 | MAP3K12 | 3.66857351 |
| 4 | EIF2AK1 | 3.60750871 |
| 5 | NTRK3 | 3.50714923 |
| 6 | NME2 | 3.48113322 |
| 7 | PBK | 3.44072524 |
| 8 | MAP2K7 | 3.41301518 |
| 9 | MAP3K4 | 3.32782473 |
| 10 | EIF2AK3 | 2.95870399 |
| 11 | SRPK1 | 2.95450815 |
| 12 | TTK | 2.93556119 |
| 13 | VRK2 | 2.67874508 |
| 14 | EPHA4 | 2.60244497 |
| 15 | PLK2 | 2.32455754 |
| 16 | CDK19 | 2.23102435 |
| 17 | MST1R | 2.21336407 |
| 18 | WEE1 | 2.20502640 |
| 19 | SCYL2 | 2.20439372 |
| 20 | AKT3 | 2.15323862 |
| 21 | MINK1 | 2.12344173 |
| 22 | CCNB1 | 2.10248555 |
| 23 | OXSR1 | 1.97318833 |
| 24 | MAP2K4 | 1.97182298 |
| 25 | TSSK6 | 1.96436849 |
| 26 | TESK1 | 1.94620248 |
| 27 | PRPF4B | 1.88529348 |
| 28 | TESK2 | 1.87341840 |
| 29 | MAP3K9 | 1.80632325 |
| 30 | MST4 | 1.77554995 |
| 31 | TRIM28 | 1.71908256 |
| 32 | MARK1 | 1.70704519 |
| 33 | BRSK2 | 1.70064363 |
| 34 | EPHA2 | 1.69538178 |
| 35 | DAPK1 | 1.65197937 |
| 36 | TNIK | 1.62358028 |
| 37 | PDK3 | 1.61185262 |
| 38 | PDK4 | 1.61185262 |
| 39 | DAPK2 | 1.60438365 |
| 40 | BCKDK | 1.51805384 |
| 41 | ARAF | 1.48638819 |
| 42 | SGK494 | 1.48067253 |
| 43 | SGK223 | 1.48067253 |
| 44 | CDC7 | 1.44200883 |
| 45 | SGK2 | 1.43953753 |
| 46 | PAK4 | 1.42407947 |
| 47 | MAPK13 | 1.38640408 |
| 48 | GRK5 | 1.36393250 |
| 49 | NTRK2 | 1.33902278 |
| 50 | PRKCG | 1.31980187 |
| 51 | SIK3 | 1.28950870 |
| 52 | IRAK3 | 1.24833934 |
| 53 | PLK4 | 1.24289430 |
| 54 | PLK1 | 1.23108966 |
| 55 | PIM2 | 1.23040978 |
| 56 | NME1 | 1.20139169 |
| 57 | BCR | 1.09695837 |
| 58 | VRK1 | 1.09586651 |
| 59 | MYLK | 1.07849796 |
| 60 | CDK5 | 1.07627241 |
| 61 | WNK3 | 1.07309619 |
| 62 | CAMK2A | 1.07215992 |
| 63 | ADRBK2 | 1.05581202 |
| 64 | AURKB | 1.04525159 |
| 65 | PDK2 | 1.00389967 |
| 66 | CAMK2B | 1.00032420 |
| 67 | NEK1 | 0.98478963 |
| 68 | BRAF | 0.97540609 |
| 69 | GRK7 | 0.97091543 |
| 70 | CAMKK2 | 0.96964346 |
| 71 | PNCK | 0.96508765 |
| 72 | KSR1 | 0.91975898 |
| 73 | BMPR1B | 0.91784548 |
| 74 | STK16 | 0.91235351 |
| 75 | MET | 0.91192634 |
| 76 | AURKA | 0.91170447 |
| 77 | PHKG1 | 0.87856016 |
| 78 | PHKG2 | 0.87856016 |
| 79 | CDK7 | 0.87198425 |
| 80 | MUSK | 0.85870514 |
| 81 | EIF2AK2 | 0.84019843 |
| 82 | PAK6 | 0.83479240 |
| 83 | PRKCE | 0.83448484 |
| 84 | MAP4K2 | 0.82694985 |
| 85 | MAP3K8 | 0.81970350 |
| 86 | ATR | 0.81238728 |
| 87 | FER | 0.80785505 |
| 88 | MKNK1 | 0.78740420 |
| 89 | CDK18 | 0.78615453 |
| 90 | SGK3 | 0.78054078 |
| 91 | NTRK1 | 0.77904000 |
| 92 | CSNK1G1 | 0.76988014 |
| 93 | UHMK1 | 0.76472661 |
| 94 | CHEK2 | 0.74469510 |
| 95 | LMTK2 | 0.74140634 |
| 96 | CHEK1 | 0.73119411 |
| 97 | STK39 | 0.72757494 |
| 98 | CAMK2D | 0.71865586 |
| 99 | CDK14 | 0.71040831 |
| 100 | CDK15 | 0.69019407 |
| 101 | ALK | 0.68549344 |
| 102 | ADRBK1 | 0.68289418 |
| 103 | BMPR2 | 0.68101616 |
| 104 | CSNK1A1L | 0.67494988 |
| 105 | PINK1 | 0.66761493 |
| 106 | PRKCI | 0.66524964 |
| 107 | CAMK2G | 0.66413162 |
| 108 | ERBB4 | 0.64657213 |
| 109 | FES | 0.64155043 |
| 110 | CDK8 | 0.62804578 |
| 111 | ERBB3 | 0.62584680 |
| 112 | CAMKK1 | 0.61542013 |
| 113 | ABL2 | 0.61141344 |
| 114 | MKNK2 | 0.60266048 |
| 115 | RPS6KA4 | 0.59981451 |
| 116 | PTK2B | 0.57305092 |
| 117 | PRKD3 | 0.57231021 |
| 118 | TNK2 | 0.56980370 |
| 119 | STK10 | 0.56913754 |
| 120 | MAPKAPK3 | 0.56633684 |
| 121 | CDK11A | 0.56399770 |
| 122 | NEK2 | 0.54822946 |
| 123 | MAP3K13 | 0.54582546 |
| 124 | WNK4 | 0.53663317 |
| 125 | CSNK1G2 | 0.53390264 |
| 126 | LIMK1 | 0.53214532 |
| 127 | CLK1 | 0.53050023 |
| 128 | SGK1 | 0.53013504 |
| 129 | RAF1 | 0.52098691 |
| 130 | AKT2 | 0.51632715 |
| 131 | PRKCH | 0.51468098 |
| 132 | PTK2 | 0.51173930 |
| 133 | NEK6 | 0.50564747 |
| 134 | CSNK2A1 | 0.49413032 |
| 135 | CSNK2A2 | 0.48607113 |
| 136 | SMG1 | 0.48399697 |
| 137 | ROCK2 | 0.46057973 |
| 138 | KSR2 | 0.45593649 |
| 139 | PLK3 | 0.45167561 |
| 140 | ATM | 0.44772465 |
| 141 | BRSK1 | 0.44680098 |
| 142 | PRKACA | 0.44266677 |
| 143 | PAK1 | 0.43279667 |
| 144 | DYRK1A | 0.41895691 |
| 145 | ZAK | 0.41829507 |
| 146 | MAPKAPK5 | 0.40632594 |
| 147 | NUAK1 | 0.39968194 |
| 148 | CSNK1E | 0.39369958 |
| 149 | CAMK1 | 0.39038802 |
| 150 | CSNK1G3 | 0.38931454 |
| 151 | MAP2K1 | 0.38097480 |
| 152 | CDK3 | 0.38083669 |
| 153 | TAF1 | 0.37339132 |
| 154 | DAPK3 | 0.36727475 |
| 155 | CDK1 | 0.36616129 |
| 156 | RIPK4 | 0.36055873 |
| 157 | ILK | 0.35643656 |
| 158 | OBSCN | 0.35203515 |
| 159 | LATS2 | 0.34977611 |
| 160 | WNK1 | 0.34953193 |
| 161 | PAK3 | 0.33102786 |
| 162 | CDK2 | 0.32232877 |
| 163 | PAK2 | 0.31439696 |
| 164 | PRKCA | 0.31424185 |
| 165 | RPS6KA3 | 0.30786597 |
| 166 | PKN1 | 0.30145837 |
| 167 | STK4 | 0.29975633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.09207751 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.99592199 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.62581864 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.28061513 |
| 5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.24556617 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.80314656 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.76713668 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60469607 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59812351 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.58867162 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.49345916 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.48778959 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26859100 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.26635326 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 2.26108634 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13247026 |
| 17 | Protein export_Homo sapiens_hsa03060 | 2.04058823 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.02458726 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.00382332 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97049548 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.96973173 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94523066 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.93430598 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.86332453 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81729725 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.79125119 |
| 27 | RNA transport_Homo sapiens_hsa03013 | 1.77294413 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.70431473 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.69517608 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67546073 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.63625618 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58728070 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57516112 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.57094356 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55611332 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54866591 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.54281898 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.53755667 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.49713507 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46327987 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45631642 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42809444 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.42440981 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39662239 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.36339780 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36039887 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36004823 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.33836614 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33622340 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32085298 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31875351 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31228331 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31170075 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31124579 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29049184 |
| 56 | Cell cycle_Homo sapiens_hsa04110 | 1.25984241 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25069683 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 1.21767217 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21481831 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21429874 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 1.20898469 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18814260 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17423652 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15852594 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12121965 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09292614 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04439427 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04235229 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 1.04102199 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.02686069 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02234404 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01415846 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97162751 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93580838 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93144089 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.92353270 |
| 77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91090001 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90290208 |
| 79 | Purine metabolism_Homo sapiens_hsa00230 | 0.90076626 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88219238 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85972711 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85130388 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84847909 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84278254 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.84053542 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81923820 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79589627 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.79439669 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78283739 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77842207 |
| 91 | Ribosome_Homo sapiens_hsa03010 | 0.77621786 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75049665 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74472887 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.72915426 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72436840 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72433907 |
| 97 | Proteasome_Homo sapiens_hsa03050 | 0.71933358 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69348786 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67504227 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63627298 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62434400 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.61517661 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57913840 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57219959 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57113460 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56234913 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.55636319 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54505581 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54304841 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52761513 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51824030 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50667956 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50458592 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48644015 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48526307 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47404111 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46786352 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46028665 |
| 119 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46007847 |
| 120 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45519014 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41917555 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41259314 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41053927 |
| 124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39861992 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.39381451 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38615417 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38157139 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37994226 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35428415 |
| 130 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35394180 |
| 131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35006558 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33972892 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33787830 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33696165 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33617878 |
| 136 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33576159 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33164000 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31545638 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31488393 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29424391 |
| 141 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28723540 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.27925889 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.27681464 |
| 144 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27547839 |
| 145 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27075700 |
| 146 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23644925 |
| 147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22447002 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22432532 |
| 149 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21445722 |
| 150 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20452531 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19853917 |
| 152 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.19761228 |
| 153 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18733584 |
| 154 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18397530 |
| 155 | Glioma_Homo sapiens_hsa05214 | 0.18257344 |
| 156 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17172479 |
| 157 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.16402677 |
| 158 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16027768 |
| 159 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15643132 |
| 160 | Mineral absorption_Homo sapiens_hsa04978 | 0.15465323 |
| 161 | Shigellosis_Homo sapiens_hsa05131 | 0.13600207 |
| 162 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.12067207 |

